Cargando…

Advances in understanding COPD

In recent years, thousands of publications on chronic obstructive pulmonary disease (COPD) and its related biology have entered the world literature, reflecting the increasing scientific and medical interest in this devastating condition. This article is a selective review of several important emerg...

Descripción completa

Detalles Bibliográficos
Autor principal: Anderson, Gary P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040155/
https://www.ncbi.nlm.nih.gov/pubmed/27746898
http://dx.doi.org/10.12688/f1000research.7018.1
_version_ 1782456199040466944
author Anderson, Gary P.
author_facet Anderson, Gary P.
author_sort Anderson, Gary P.
collection PubMed
description In recent years, thousands of publications on chronic obstructive pulmonary disease (COPD) and its related biology have entered the world literature, reflecting the increasing scientific and medical interest in this devastating condition. This article is a selective review of several important emerging themes that offer the hope of creating new classes of COPD medicines. Whereas basic science is parsing molecular pathways in COPD, its comorbidities, and asthma COPD overlap syndrome (ACOS) with unprecedented sophistication, clinical translation is disappointingly slow. The article therefore also considers solutions to current difficulties that are impeding progress in translating insights from basic science into clinically useful treatments.
format Online
Article
Text
id pubmed-5040155
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-50401552016-10-13 Advances in understanding COPD Anderson, Gary P. F1000Res Review In recent years, thousands of publications on chronic obstructive pulmonary disease (COPD) and its related biology have entered the world literature, reflecting the increasing scientific and medical interest in this devastating condition. This article is a selective review of several important emerging themes that offer the hope of creating new classes of COPD medicines. Whereas basic science is parsing molecular pathways in COPD, its comorbidities, and asthma COPD overlap syndrome (ACOS) with unprecedented sophistication, clinical translation is disappointingly slow. The article therefore also considers solutions to current difficulties that are impeding progress in translating insights from basic science into clinically useful treatments. F1000Research 2016-09-27 /pmc/articles/PMC5040155/ /pubmed/27746898 http://dx.doi.org/10.12688/f1000research.7018.1 Text en Copyright: © 2016 Anderson GP http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Anderson, Gary P.
Advances in understanding COPD
title Advances in understanding COPD
title_full Advances in understanding COPD
title_fullStr Advances in understanding COPD
title_full_unstemmed Advances in understanding COPD
title_short Advances in understanding COPD
title_sort advances in understanding copd
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040155/
https://www.ncbi.nlm.nih.gov/pubmed/27746898
http://dx.doi.org/10.12688/f1000research.7018.1
work_keys_str_mv AT andersongaryp advancesinunderstandingcopd